Biotech

Biotech Pharmaceutical

Aptamer Drugs: The Next Generation of “Chemical Antibodies

Aptamers are a class of therapeutic molecules often called “chemical antibodies” because they perform the same function as traditional antibody drugs (binding to a target), but they are made from an entirely different material: short strands of nucleic...

Biotech Pharmaceutical Sci&Tech

A Comprehensive Analysis of ADME Challenges for PROTACs

Proteolysis-targeting chimera (PROTAC) molecules have emerged as a revolutionary approach in drug discovery, offering the potential to selectively degrade target proteins. However, their design, characterized by a bivalent structure comprising a target protein-binding ligand (warhead), an E3...

Biotech Industry

The foundations of a biotech startup

A biotech startup is a complex endeavor, requiring a strong foundation in science, business, and regulatory affairs.Here are the key elements: 1. A Strong Scientific Idea or Technology: Novelty: The technology should be novel and have the potential...

Biotech Industry Pharmaceutical

Biotech Business Model：Hub-and-Spoke

The biotechnology business model is characterized by high risk, high reward, and a long development timeline. There is an increasing trend of “hub and spoke” business models, where companies have multiple subsidiary companies, each focused on...

Biotech GLP Industry Pharmaceutical Regulation

Understanding about the FDA’s Embrace of New Approach Methodologies

In a landmark decision signaling a paradigm shift in pharmaceutical safety assessment, the U.S. Food and Drug Administration (FDA) announced on April 10, 2025, a plan to phase out the requirement for animal testing in the...

Biotech Industry Pharmaceutical

How to identify lead compounds in drug discovery

Identifying drug lead compounds, the starting point for drug development, is a crucial and multifaceted process. Here’s a breakdown of some key strategies employed in this scientific endeavor: 1. Target Identification and Validation: The journey begins...

Biotech GLP Industry Pharmaceutical

Keys for selecting preclinical drug candidate

Selecting a preclinical candidate is a critical step in drug development. It is a million dollars decision. It involves choosing the most promising drug molecule from a pool of candidates to move forward for further testing. Obviously, the...

Biotech Industry Pharmaceutical

What does BD do and how to become a BD in biotech

In the world of biotech, a Business Development (BD) professional plays a critical role in forging strategic partnerships, identifying and securing licensing deals, and driving the overall growth of the company. Here’s a breakdown of their...

Biotech Industry Pharmaceutical

The consideration of working with pharmaceutical contract service organizations

The pharmaceutical industry has witnessed a paradigm shift, with contract service organizations (CSOs) emerging as powerful contributors across the spectrum of research, development, and manufacturing. These partnerships unlock access to specialized expertise, infrastructure, and economies of scale....

Biotech Industry

The biotech company numbers by the country

First of all, this article is just a recap of the OECD statistics. If you are interested in the topic, I would recommend a nice article at Labbiotech. The OECD’s latest update on key biotech indicators highlights rising...